All trades / ACOG
59Open-market trades
+19.9%Avg 90d after buys
+30.1%Avg 90d after sales
+48.0%Avg 180d after buys
Price and insider prints
ACOG adjusted close▲ buy▼ sale
Trades
| Date | Form 4 | Ticker | Insider | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|---|
| 9/16/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 53,029 | $454.6K | +24.6%hist | +12.3%hist | |
| 9/16/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 27,141 | $228.0K | +24.6%hist | +12.3%hist | |
| 9/15/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 3,375 | $28.8K | +24.6%hist | +12.3%hist | |
| 9/14/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 40,373 | $351.1K | +24.6%hist | +12.3%hist | |
| 8/21/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Wills Robert JamesDirector | BUY | 10,000 | $96.2K | −25.6%hist | −30.7%hist | |
| 8/3/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 50,000 | $400.0K | +24.6%hist | +12.3%hist | |
| 7/31/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,900 | $23.0K | +24.6%hist | +12.3%hist | |
| 7/24/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 130 | $1.0K | +24.6%hist | +12.3%hist | |
| 7/23/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 49,849 | $388.6K | +24.6%hist | +12.3%hist | |
| 7/22/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 10,000 | $78.3K | +24.6%hist | +12.3%hist | |
| 7/22/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 140,237 | $1.10M | +24.6%hist | +12.3%hist | |
| 6/26/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 152,336 | $975.0K | +24.6%hist | +12.3%hist | |
| 6/25/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 197 | $1.3K | +24.6%hist | +12.3%hist | |
| 6/15/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 4,550 | $27.3K | +45.4% | +12.3%hist | |
| 6/12/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 273 | $1.6K | +48.6% | +12.3%hist | |
| 6/11/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,862 | $16.9K | +51.2% | +12.3%hist | |
| 6/10/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 5,872 | $35.2K | +58.9% | +12.3%hist | |
| 6/9/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 24,856 | $148.6K | +58.7% | +12.3%hist | |
| 6/5/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 10,054 | $58.6K | +58.2% | +12.3%hist | |
| 5/29/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 70,577 | $416.4K | +57.3% | +12.3%hist | |
| 5/28/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,000 | $11.7K | +58.4% | +12.3%hist | |
| 5/27/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 1,161 | $6.7K | +70.2% | +12.3%hist | |
| 5/21/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 15,945 | $90.9K | +52.7% | +12.3%hist | |
| 5/20/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 8,431 | $49.7K | +45.6% | +12.3%hist | |
| 5/19/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | D'Angelo LaurenChief Operating Officer | BUY | 3,500 | $20.2K | +52.4% | — | |
| 5/18/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 17,395 | $99.0K | +53.7% | +12.3%hist | |
| 5/15/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 16,648 | $97.1K | +43.4% | +12.3%hist | |
| 3/30/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 1,850 | $9.2K | +28.0% | +12.3%hist | |
| 3/27/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 10,000 | $50.8K | +28.0% | +12.3%hist | |
| 3/26/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 7,319 | $38.6K | +23.2% | +12.3%hist | |
| 3/25/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 8,581 | $46.6K | +23.6% | +12.3%hist | |
| 3/24/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 4,182 | $23.4K | +20.9% | +12.3%hist | |
| 3/19/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,094 | $12.0K | +14.4% | +50.7% | |
| 3/18/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,481 | $14.3K | +4.52% | +51.5% | |
| 3/16/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 1,331 | $7.7K | +3.45% | +50.4% | |
| 3/13/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 7,358 | $42.3K | +5.04% | +58.8% | |
| 3/12/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 5,708 | $33.4K | +2.39% | +62.7% | |
| 3/9/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,179 | $12.7K | +2.56% | +62.2% | |
| 3/6/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 1,900 | $11.0K | +2.07% | +60.9% | |
| 3/5/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 42,023 | $243.7K | +5.92% | +59.8% | |
| 3/5/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 5,000 | $29.0K | +5.92% | +59.8% | |
| 3/4/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 19,795 | $115.0K | +5.46% | +58.2% | |
| 3/3/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 5,000 | $28.8K | +10.3% | +61.2% | |
| 3/3/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 46,411 | $266.9K | +10.3% | +61.2% | |
| 3/2/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 20,000 | $116.0K | +9.31% | +59.8% | |
| 2/27/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 3,638 | $21.8K | −1.00% | +56.8% | |
| 2/26/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 590 | $3.5K | −4.50% | +62.5% | |
| 2/24/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 53,591 | $310.8K | −2.16% | +62.2% | |
| 2/24/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 5,000 | $29.0K | −2.16% | +62.2% | |
| 2/23/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 4,181 | $24.6K | −0.17% | +65.5% | |
| 2/23/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 95,819 | $564.4K | −0.17% | +65.5% | |
| 2/20/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 2,819 | $16.5K | −0.51% | +52.0% | |
| 2/20/2026 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Opaleye Management Inc.10% owner | BUY | 10,000 | $58.4K | −0.51% | +52.0% | |
| 8/18/2025 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | MERTZ PHILLIP JOSEPHDirector | SELL | 27,778 | $250.0K | +30.1% | +38.3% | |
| 8/18/2025 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | Wills Robert JamesDirector | BUY | 15,000 | $127.3K | −30.1% | −38.3% | |
| 8/18/2025 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | MERTZ LEONARD POWELLDirector | BUY | 27,778 | $250.0K | −30.1% | −38.3% | |
| 11/13/2024 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | HAVENS JOHN PRENTISSDirector | BUY | 4,347 | $25.0K | +1.92% | +29.8% | |
| 11/13/2024 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | McFadden Michael E.Chief Executive Officer | BUY | 2,608 | $15.0K | +1.92% | +29.8% | |
| 11/13/2024 | ACOGAlpha Cognition Inc Alpha Cognition Inc · Biological Products, (No Diagnostic Substances)IndustryBiological Products, (No Diagnostic Substances)Mkt cap (est.)$250.14MPrice$8.8352w high$9.7552w low$4.50 | MERTZ LEONARD POWELLDirector | BUY | 8,695 | $50.0K | +1.92% | +29.8% |
Chart shows split-adjusted close for the last three years, or the selected date range. Triangles mark open-market Form 4 purchases and sales in that window.